High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment
Emily K. Sims, Susan Geyer, S. Alice Long, Kevan C. Herold
Topics & Concepts
ProinsulinType 2 diabetesMedicineInternal medicineDiabetes mellitusPlaceboC-peptideType 1 diabetesOncologyEndocrinologyDiseaseImmunotherapyImmunologyCancerPathologyAlternative medicineDiabetes and associated disordersDiabetes Management and ResearchT-cell and B-cell Immunology